Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name Civitas Therapeutics, Inc. Proposed Ticker CVTS CUSIP 17887L105 Business Description A biopharmaceutical company focused on developing and commercializing transformative therapeutics using our proprietary ARCUS technology, with an initial focus on treating debilitating OFF episodes, the unpredictable re-emergence of symptoms, in patients with Parkinson’s disease, or PD. Lead Underwriter BofA Merrill Lynch, J.P. Morgan Securities LLC Co-Managers Cowen and Company, LLC, Oppenheimer and Co., Inc Initial Shares 50,00,000 Revised Initial Shares N/A Initial Price $14.00-$16.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.